<<

. 2
( 2 .)







































oaeie oa?aiee. A ?aeiiaiaaoeyo AIC 2003 a. aaiiue aea











































oa?aiee (a/n aaaaaiey AE) ia oeao?e?o?o. Ianaeaeoeaiua



































IIAI, iniaaiii i?e aeeoaeuiii i?eaia, oooaoa?o iaoa-






?en. 2. Aeeyiea ia neioac AAA ?acee?iuo IIAI [19]
eOCaAieaeEau
progression of osteoarthritis of the knee” J. Rheum., 1995, 22: 1941–1946.
19. Rashad S., Revell P., Hemingway A. et.al. “Effect of non–steroidal anti–inflammatory
! drugs on the course of osteoarthritis.” Lancet, 1989, i: 519–522.
/ – 20. Howell D.S., Pita J.C., Muller F.J. et.al. “Treatment of OA with tiaprofenic acid: bio-
chemical and histological protection against cartilage breakdown in the Pond–Nuki
canine model.” J. Rheum., 1991, 18 Suppl. 27: 138–142
21. Blot L., Marcelis A., Devogelaer J.P., Manicourt D.H. “Effects of diclofenac,
aieeci o?yua, onoaoaeyy oa?aiea IA. Niaoeoe?aneee aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan
eiaeaeoi? OIA–2 – i?aia?ao Oaeaa?aen ia oieuei ia iea- in osteoarthritic human articular cartilage.” Br. J. Pharmacol., 2000, 131:
cuaae io?eoaoaeuiiai aeeyiey ia iaoaaieeci o?yua, ii 1413–1421
22. Hajjal H.E.L., Marcelis A., Devogelaer J–P., Manicourt D–H. “Celecoxib has a positive
e i?iaaiiino?e?iaae iiceoeaiia aeeyiea ia neioac aea-
effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthrit-
eo?iiaia a o?yua ?aeiaaea.
ic cartilage.” J. Rheum., 2003,30: 2444–2451

aEUA?UU?
!
1. Garcia Rodriguez L.A., Hernandez–Diaz S. “The relative risk of upper gastrointestinal
complications among users of acetaminophen and non–steroidal anti–inflammatory
drugs.” Epidemiology, 2001, 12: 570–576.

2. Adams P.F., G.E. Hendershot E M.A. Marano. “Current Estimates from the National
Health Interview Survey.” 1996. National Center for Health Statistics. Vital Health Stat
10(2000). 1999. 23. Mastberger S.C., Lafeber F.P., Bijlsma J.W. “Selective COX–2 inhibition prevents
3. Ruoff G. Management of pain in patients with multiple health problems: a guide for the proinflammatory cytocin–induced cartilage damage.” Rheumat., 2002, 41: 801–808.
practicing physician. Amer. J. Med., 1998; 105 (1B):53S–60S. 24. O.a. cOOIO‚, c.C. oE?OO‚, C.u. aO‚IA‚ «EI?IOIO?UEIOE? ‚ ?A‚IUOIO„EE»
4. Janssen M., Dijkmans B., van der Sluijs F.A. «Upper gastrointestinal complaints and aOOI‚. 1998.
complication in chronic rheumatic patients in comparison with other chronic diseases» 25. O.a. cOOIO‚ «AOIA‚OE OEI?OI O?E OUOIO„EE OOO?IO–‚E„UAI?IO„O OO?U»
Br.J.Rheum., 1992., Vol.31: 747–752. C??, 4, 2002, OU?. 15–19.
5. cOOIO‚ C.A., eE„EEI u.A. «eUO„AIAUE?AOI? UA?OE? ?A‚IUE?AOIE? A·OIA‚- 26. «iOIO‚E? E U?A·O‚IE? I ‚IUU?EOUOU‚IOIU E OA?E?UEIUI??IOIU ‚‚AAIE? „I?-
IEE»., a., 1985, 58–63 IOIO?UEIOOUA?OEI?? O?AO?UO‚» aAUOE?AOIEA UIAIE? 2001/25 aEIEOUA?OU-
6. Haskisson E.C. “Clinical aspects of chondroprotection”. Sem. Arthr. Rheum., 1990, ‚ A?‚OO??IAIE? ei, a., 2001.
V.19, 30–32 27. K. Gaffiney, J. Ledingham, J. Perry «Intra–articular triamcinolone hexacetomid in
7. Doherty M. “Chondroprotection by nonsteroidal anti–inflammatory drugs”. Ann. knee osteoarthritis: factor influencing the clinical response». Ann.Rheum.Dis., 1995; 54:
Rheum. Dis., 1989, V.48: 619–621 379–381.
8. Brandt K.D. “The mechanism of action of nonsteroidal anti–inflammatory drugs”. J. 28. Kaiser H., Kley H. «Cortisontherapie: Corticoide in Klinik und Praxis.“ Georg Thieme
Rheum., 1991, V.18: 120–121 Verlag, Stutgart, New York, 1997
9. Ostensen M. “Cartilage changes in arthritis do non–steroidal antiphlogistics have pos- 29. Reid D., Eastmond C., Rennie J. «Hypotalamo–pituitary–adrenal axis suppression
itive or negative effects?” Tiddsskr–Nor–Laegeforen, 1991, V. 111, 838–840 after repeated intra–articular steroid injection.» Ann.Rheum.Dis., 1986, 45: 45–87.
10. Manicourt D.H., Pita J.C. “Progressive depletion of hyaluronic acid in early experi- 30. O.a. cOOIO‚ «e?OUE‚O‚OOOIEUAI?I? UA?OE? ?A‚IUE?AOIE? A·OIA‚IEE». a.
mental osteoarthritis in dogs.” Arthr. Rheum., 1988, 31: 538–544 «a–eaia», 1996, 345 OU?.
11. Sweet M.B., Thonar E.J., Immelman A.R., Solomon L. “Biochemical changes in pro- 31. Gray R., Tenenbaum J., Dottlieb N., et.al., «Local corticosteroid injection treatment in
gressive osteoarthrosis.” Ann. Rheum. Dis.,1977, 36: 387–398. rheumatic disorders» Sem.Arthr.Rheum., 1981, 10: 231–254.
12. Thonar E.J., Sweet M.B., Immelman A.R., Lyons G. “Hyaluronate in articular cartilage: 32. Gray R., Tenenbaum J., Dottlieb N., et.al., «Local corticosteroid injection treatment in
age–related changes.” Calcif. Tissue Res., 1978, 26: 19–21. rheumatic disorders» Sem.Arthr.Rheum., 1981, 10: 231–254.
13. Rizkalla G., Reiner A., Bogoch T., Poole A.R. ”Studies of the articular cartilage pro- 33. Todhunter R., Fubini S., Wooton J., Lust G. «Effect of methylprednisolon acetate on
teoglycan aggrecan in health and osteoarthritis. Evidence of molecular heterogeneity and proteoglycan and collagen metabolism of articular cartilage explants.» J.Rheum., 1996,
extensive molecular changes in disease.” J. Clin. Res., 1992, 90: 2268–2277. 23: 1207–1213.
14. Holmes M.W., Bayliss M.T., Muir H. “Hyaluronic acid in human articular cartilage.
Age–related changes in content and size.” Biochem. J., 1988, 250: 435–441.
15. Meyer–Carrive I., Ghosh P “Effects of tiaprofenic acid (Surgam) on cartilage proteo-
glycans in the rabbit joint immobilization model”. Ann. Rheum. Dis., 1992, V.51:448–455
16. Vries B.J., Van der Berg W. NImpact of NSAIDS on murine antigen induced arthritis.
A light microscopic investigation of anti–inflammatory and bone protective effects”. J.
Rheum., 1990, V 17: 295–303
17. “Osteoarthritis. Clinical and Experimental aspects.” Ed.J.–E. Reginster, J.–P. Pelletier,
Y. Henrotin. Springer, 1999.
18. Haskinsson E.C., Berry H., Gishen P. et.al. “Effects of anti–inflammatory drugs on the
(% )




%
( )








?en. 4. Oaaee?aiea ia?aciaaiey (3H)–iieaeoe
?en. 3. Io?eoaoaeuiia aaenoaea eeanne?aneeo IIAI
ia o?yu [18,19] i?ioaiaeeeaiia ia oiia i?eiaiaiey oaeaa?aena [22]



542 13, 8, 2005

<<

. 2
( 2 .)